---
document_datetime: 2023-09-21 18:49:18
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/ceprotin-epar-all-authorised-presentations_en.pdf
document_name: ceprotin-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7748086
conversion_datetime: 2025-12-19 14:09:01.512881
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU Number       | Invented name   | Strength   | Pharmaceutical form                           | Route of administration   | Packaging                                  | Content (concentration)                    | Package size    |
|-----------------|-----------------|------------|-----------------------------------------------|---------------------------|--------------------------------------------|--------------------------------------------|-----------------|
| EU/1/01/190/001 | CEPROTIN        | 500 IU     | Powder and solvent for solution for injection | Intravenous use           | Powder: vial (glass) Solvent: vial (glass) | Powder: 500 IU Solvent: 5 ml (100 IU/ml)   | 1 vial + 1 vial |
| EU/1/01/190/002 | CEPROTIN        | 1000 IU    | Powder and solvent for solution for injection | Intravenous use           | Powder: vial (glass) Solvent: vial (glass) | Powder: 1000 IU Solvent: 10 ml (100 IU/ml) | 1 vial + 1 vial |